The cornerstone for managing DIC remains the management of the underlying cause (e.g., sepsis). Guidelines for management are based mainly on expert opinion, which suggests replacement of coagulation proteins and platelets in patients who are bleeding. The use of antifibrinolytic agents is contraindicated in the management of DIC, since the fibrinolytic system is required in recovery to ensure the dissolution of the widespread fibrin. - See more at: blogs.nejm.org/now/index.php/bleeding-and-coagulopathies-in-critical-care/2014/02/28#sthash.Ef4z8xvi.dpuf
Posted on: Tue, 04 Mar 2014 02:50:38 +0000
Trending Topics
Recently Viewed Topics
© 2015